Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.5K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

16.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.1K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.0K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.0K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Essential role of VGLUT2-negative claustro-prefrontal projections in working memory.

Current biology : CB·2026
Same author

Differential Effects of Retinal Fatty Acids Under Oxidative Stress Reveal DHA's Susceptibility to Ferroptosis and Polarity Disruption in iPSC Derived RPE Cells.

Stem cell reviews and reports·2026
Same author

Mapping the functional connectome of the claustrum: Noise filtering via local inhibitory circuits.

Cell reports·2026
Same author

Chronic cerebral hypoperfusion induces venous dysfunction via EPAS1 regulation in mice.

Nature communications·2025
Same author

Cell-Based Assays Using Derived Human-Induced Pluripotent Cells in Drug Discovery and Development.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Human-Induced Pluripotent Stem Cell-Derived Definitive Endoderm Bulk Up and Hepatic Differentiation.

Methods in molecular biology (Clifton, N.J.)·2025

Related Experiment Video

Updated: Jan 24, 2026

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

5.0K

Cell-Based Assays Using Differentiated Human Induced Pluripotent Cells.

Zameel Cader1, Martin Graf2, Mark Burcin2

  • 1Translational Molecular Neuroscience Group, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Methods in Molecular Biology (Clifton, N.J.)
|May 25, 2019
PubMed
Summary
This summary is machine-generated.

This study outlines requirements for using human induced pluripotent stem cell (iPSC) lines in pharmaceutical assay development. A collaborative network successfully created patient-specific iPSC lines and disease models for drug discovery.

Keywords:
Differentiation protocolsDisease modelsInduced pluripotent celliPSC

More Related Videos

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
07:37

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells

Published on: June 11, 2019

9.2K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Related Experiment Videos

Last Updated: Jan 24, 2026

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

5.0K
Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells
07:37

Efficient Differentiation of Human Pluripotent Stem Cells into Liver Cells

Published on: June 11, 2019

9.2K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Area of Science:

  • Biotechnology
  • Stem Cell Research
  • Pharmaceutical Sciences

Background:

  • Pharmaceutical drug discovery relies on robust cellular models.
  • Human induced pluripotent stem cells (iPSCs) offer a promising source for patient-specific disease modeling.
  • Standardized protocols are needed for integrating iPSC technology into drug development pipelines.

Purpose of the Study:

  • To define the requirements and preconditions for utilizing human iPSC lines in pharmaceutical assay development.
  • To highlight the collaborative StemBANCC consortium's role in implementing iPSC-derived cellular models.
  • To showcase the successful derivation of patient-specific iPSC lines and disease-relevant assays.

Main Methods:

  • Collaboration between academic institutions and pharmaceutical partners.
  • Derivation and characterization of numerous patient-specific iPSC lines.
  • Establishment of disease-relevant cellular assays using iPSC derivatives.

Main Results:

  • A significant number of well-characterized patient-specific iPSC lines were successfully generated.
  • Disease-relevant cellular assays were established, meeting industry requirements.
  • The StemBANCC consortium facilitated the implementation of iPSC models for drug discovery.

Conclusions:

  • Meeting specific requirements enables the use of iPSC lines in pharmaceutical assay development.
  • Collaborative efforts are crucial for advancing iPSC technology in drug discovery.
  • Patient-specific iPSC models contribute to the development of safer and more efficacious medicines.